Rheumatoid arthritis treatment Archives | Page 3 of 8 | Rheumatoid Arthritis Warrior

Rheumatoid arthritis treatment

Xeljanz Cost with a Copay Card, Free Samples, Efficacy, & Side Effects: Gathering Rheumatoid Arthritis Patient Stories

Kelly O'Neill 137 Comments ,
Please share your experiences with Xeljanz on the comments page here. Patient stories are starting to come in across the blog and I thought this would be more convenient for others searching for answers. Here’s my story. A copay card for the newly approved DMARD, Xeljanz Two years ago, my rheumatologist recommended I “just wait for something...Continue reading      137 Comments » Read more

10 Answers to “When Do I Start a Biologic Treatment for Rheumatoid Arthritis?”

Kelly O'Neill 45 Comments ,
Patients ask: How do I know it’s time to start a biologic? This question was recently posted on our Facebook page and it’s one most patients ask at some point. Initiating Biologic therapy is a decision that is obviously made together with your doctor. Here are some factors in this important decision.   One important source of information:...Continue reading      45 Comments » Read more

Rheumatoid Arthritis Drug Approved by US FDA: Pfizer’s Xeljanz Pill (Tofacitinib)

Kelly O'Neill 35 Comments ,
For over two and a half years, we’ve followed Pfizer’s tofacitinib through clinical trials for FDA approval. Today, the U.S. FDA approved the new drug that will be called Xeljanz. Click here to read the full Pfizer press release for Xeljanz.   The first JAK for Rheumatoid Arthritis approved: “Xeljanz” The U.S. Food and Drug Administration (FDA) announced...Continue reading      35 Comments » Read more

Pfizer’s Rheumatoid Arthritis Pill Approved by Food and Drug Administration (FDA)

Kelly O'Neill 7 Comments ,
Note: Click here to read more about Xeljanz, the first new oral medication for Rheumatoid Arthritis in 10 years, and a short list of questions and answers for patients. Sign up for regular blog updates by email to watch for more updates on this new treatment and others. Pfizer press release about Xeljanz NEW YORK--(BUSINESS WIRE)--Pfizer...Continue reading      7 Comments » Read more

The End of the Methotrexate Shortage, Thanks to Pfizer?

Kelly O'Neill 21 Comments ,
Pfizer addresses U.S. methotrexate shortage that hurts RA patients Earlier this year the FDA approved an abbreviated new drug application, securing Pfizer’s right to sell injectable methotrexate in the U.S. Recently, Pfizer says they began shipping to customers. This move by Pfizer addresses an urgent shortage of methotrexate in the U.S. that has affected many Rheumatoid...Continue reading      21 Comments » Read more

Side Effects and Genes: More Evidence for Listening to Patients

Kelly O'Neill 14 Comments , ,
Some readers say medical terms bug them. Wait! Don’t let the weird words in an abstract make your eyes glaze over. Sometimes there’s important stuff there!  You might still get the general idea if you just read “the whatever” when you get to a word you can’t pronounce. Then look up significant words if you...Continue reading      14 Comments » Read more

Why say a patient #FAILS treatment when RA treatments fail patients?

Kelly O'Neill 39 Comments ,
RA patients are brave and optimistic, as I’ve said. I’ve never been around such a hopeful, resilient crowd. We continually adjust because the disease is progressive and persistent. And we repeatedly hope for the best because there is always one more treatment or therapy to try. Rolling with the punches gracefully becomes sport for us. We...Continue reading      39 Comments » Read more
“imaware™
    Advertisement

Would You Like Free Email Updates?

Stay in touch with RA Warrior.

We respect your privacy. Your email address will never be shared.